当前位置: X-MOL 学术Blood Cancer J. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Sustained remission following finite duration bispecific antibody therapy in patients with relapsed/refractory myeloma
Blood Cancer Journal ( IF 12.9 ) Pub Date : 2024-08-12 , DOI: 10.1038/s41408-024-01114-7
Rajshekhar Chakraborty 1 , Heloise Cheruvalath 2 , Anannya Patwari 2 , Aniko Szabo 2 , Carolina Schinke 3 , Binod Dhakal 2 , Suzanne Lentzsch 1 , Anita D'Souza 2 , Ghulam Rehman Mohyuddin 4 , Kelley Julian 4 , Shonali Midha 5 , Patrick Costello 5 , Martin Kaiser 6 , Melissa Ng Liet Hing 7, 8 , Simon J Harrison 7, 8 , Edward R Scheffer Cliff 7, 8 , Meera Mohan 2
Affiliation  



中文翻译:


复发/难治性骨髓瘤患者有限持续时间双特异性抗体治疗后的持续缓解


更新日期:2024-08-12
down
wechat
bug